ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

Bayer To Develop Cancer Treatment With Amgen

FRANKFURT -(Dow Jones)- German chemical and pharmaceutical company Bayer AG (BAYN.XE) said Tuesday it has agreed with Amgen Inc. (AMGN) to develop and commercialize a new antibody for treating cancer. MAIN FACTS: -Financial details of the deal weren't disclosed. -Bayer will collaborate with Amgen at its Munich site from the research phase to the completion of initial clinical trials. -After the initial trials have been completed, Bayer will be responsible for further development and commercialization of the product candidate. -In 2009, Bayer had entered into an agreement with Micromet, Inc. to produce another antibody. -Micromet was acquired by Amgen in early 2012. -Frankfurt Bureau, Dow Jones Newswires; 49-69-29725-500

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
05/27/201516:30:00Amgen To Present At The Jefferies 2015 Global Healthcare Conference
05/27/201516:00:00Amgen To Advance Understanding Of The Treatment Of Blood Cancers...
05/26/201516:14:00Pivotal Study Results Published in Journal of Clinical Oncology...
05/26/201502:44:47SUBSCRIBERS: AstraZeneca Terminates Pact with Amgen Already Reported
05/25/201509:50:13The Best Business Model in Biotech
05/25/201509:45:09The Best Business Model in Biotech
05/25/201509:40:05The Best Business Model in Biotech
05/25/201509:35:04The Best Business Model in Biotech
05/25/201509:30:09The Best Business Model in Biotech
05/25/201509:25:06The Best Business Model in Biotech
05/25/201509:20:07The Best Business Model in Biotech
05/25/201509:15:08The Best Business Model in Biotech
05/25/201509:10:06The Best Business Model in Biotech
05/25/201509:05:04The Best Business Model in Biotech
05/25/201509:00:08The Best Business Model in Biotech
05/25/201508:55:05The Best Business Model in Biotech
05/25/201508:50:08The Best Business Model in Biotech
05/25/201508:45:08The Best Business Model in Biotech
05/25/201508:40:06The Best Business Model in Biotech
05/25/201508:35:06The Best Business Model in Biotech

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad